Sulfacetamide Sodium NDC 45802-896

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-896Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0896Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
45802-896-26	45802089626	118 mL in 1 BOTTLE, PLASTIC (45802-896-26)Marketed from Oct 17, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfacetamide Sodium
Generic name (nonproprietary): sulfacetamide sodium
Active ingredients: Sulfacetamide sodium — 100 mg/mL
Dosage form: Lotion
Route: Topical
Labeler: Padagis Israel Pharmaceuticals Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078649
Marketing start: Oct 17, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 45802-896_03f16a28-7c10-4fa0-a4c8-ac29335c6be7SPL ID 03f16a28-7c10-4fa0-a4c8-ac29335c6be7SPL set ID 4fb4d39a-330e-4c84-abbc-3b33b36b206fRxCUI 1006688UNII 4NRT660KJQ
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802089626 followed by a unit qualifier and the quantity

Package 45802-0896-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2023.

Indications (excerpt from the label)

INDICATIONS Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion) is indicated in the topical treatment of acne vulgaris .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)